STSA — Satsuma Pharmaceuticals Balance Sheet
0.000.00%
HealthcareSpeculativeMicro Cap
- $36.47m
- -$4.90m
Annual balance sheet for Satsuma Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5.21 | 108 | 68.2 | 93.2 | 52.5 |
Prepaid Expenses | |||||
Total Current Assets | 5.4 | 115 | 73.8 | 99.8 | 54.8 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.445 | 0.832 | 6.47 | 6.79 | 0.108 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 6.38 | 126 | 81 | 110 | 54.9 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.97 | 7.97 | 8.05 | 8.49 | 8.12 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 6.87 | 10.9 | 9.1 | 8.49 | 8.12 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.484 | 115 | 71.9 | 101 | 46.8 |
Total Liabilities & Shareholders' Equity | 6.38 | 126 | 81 | 110 | 54.9 |
Total Common Shares Outstanding |